These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 20847448

  • 1. Changed clathrin regulatory proteins in the brains of Alzheimer's disease patients and animal models.
    Cao Y, Xiao Y, Ravid R, Guan ZZ.
    J Alzheimers Dis; 2010; 22(1):329-42. PubMed ID: 20847448
    [Abstract] [Full Text] [Related]

  • 2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 3. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.
    J Alzheimers Dis; 2010 Sep 23; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [Abstract] [Full Text] [Related]

  • 4. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y, Hua Q, Lei H, Li P.
    J Ethnopharmacol; 2011 Sep 02; 137(2):1035-46. PubMed ID: 21798326
    [Abstract] [Full Text] [Related]

  • 5. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP, Giardino L, Sivilia S, Giuliani A, Gusciglio M, Pietrini V, Del Giudice E, D'Arrigo A, Leon A, Villetti G, Calzà L.
    J Alzheimers Dis; 2010 Sep 02; 20(1):159-73. PubMed ID: 20164581
    [Abstract] [Full Text] [Related]

  • 6. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC.
    J Alzheimers Dis; 2010 Sep 02; 20(1):113-26. PubMed ID: 20164597
    [Abstract] [Full Text] [Related]

  • 7. Preserved synaptic vesicle recycling in hippocampal neurons in a mouse Alzheimer's disease model.
    Yao PJ, Bushlin I, Furukawa K.
    Biochem Biophys Res Commun; 2005 Apr 29; 330(1):34-8. PubMed ID: 15781228
    [Abstract] [Full Text] [Related]

  • 8. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
    Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R.
    Neurodegener Dis; 2010 Apr 29; 7(1-3):88-95. PubMed ID: 20173334
    [Abstract] [Full Text] [Related]

  • 9. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T, Ogino K, Shin RW, Kitamoto T, Kikuchi T, Shimizu N.
    Neurosci Lett; 2010 Jan 22; 469(2):273-7. PubMed ID: 20025930
    [Abstract] [Full Text] [Related]

  • 10. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J.
    Neuroscience; 2006 Dec 28; 143(4):911-22. PubMed ID: 17027170
    [Abstract] [Full Text] [Related]

  • 11. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.
    Simón AM, de Maturana RL, Ricobaraza A, Escribano L, Schiapparelli L, Cuadrado-Tejedor M, Pérez-Mediavilla A, Avila J, Del Río J, Frechilla D.
    J Alzheimers Dis; 2009 Dec 28; 17(4):773-86. PubMed ID: 19542617
    [Abstract] [Full Text] [Related]

  • 12. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

  • 13. Lesion-induced hippocampal plasticity in transgenic Alzheimer's disease mouse models: influences of age, genotype, and estrogen.
    Kadish I, van Groen T.
    J Alzheimers Dis; 2009 Nov 03; 18(2):429-45. PubMed ID: 19584452
    [Abstract] [Full Text] [Related]

  • 14. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR.
    Neurochem Int; 2006 Dec 03; 49(7):631-9. PubMed ID: 16814428
    [Abstract] [Full Text] [Related]

  • 15. Memory-related deficits following selective hippocampal expression of Swedish mutation amyloid precursor protein in the rat.
    Gong Y, Meyer EM, Meyers CA, Klein RL, King MA, Hughes JA.
    Exp Neurol; 2006 Aug 03; 200(2):371-7. PubMed ID: 16780838
    [Abstract] [Full Text] [Related]

  • 16. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.
    Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725
    [Abstract] [Full Text] [Related]

  • 17. Effects of triptolide on the synaptophysin expression of hippocampal neurons in the AD cellular model.
    Nie J, Zhou M, Lü C, Hu X, Wan B, Yang B, Li Y.
    Int Immunopharmacol; 2012 Jun 15; 13(2):175-80. PubMed ID: 22498763
    [Abstract] [Full Text] [Related]

  • 18. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF.
    Eur J Neurosci; 2006 Jan 15; 23(1):251-60. PubMed ID: 16420434
    [Abstract] [Full Text] [Related]

  • 19. Dynamin 1 depletion and memory deficits in rats treated with Abeta and cerebral ischemia.
    Watanabe T, Iwasaki K, Takasaki K, Yamagata N, Fujino M, Nogami A, Ii M, Katsurabayashi S, Mishima K, Fujiwara M.
    J Neurosci Res; 2010 Jul 15; 88(9):1908-17. PubMed ID: 20127811
    [Abstract] [Full Text] [Related]

  • 20. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W, Liu Y, Liu S, Walter S, Grimm MO, Kiliaan AJ, Penke B, Hartmann T, Rübe CE, Menger MD, Fassbender K.
    Brain; 2011 Jan 15; 134(Pt 1):278-92. PubMed ID: 21115468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.